Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
JXSL1600079 | Ixekizumab(LY2439821)注射剂 | ixekizumab | Injection | Biological Products | Import Drug Application | 2017-01-12 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2018-01-16 | view |
JXSS1900010 | Ixekizumab注射液 | ixekizumab | Injection | Biological Products | Import Drug Application | 2019-03-01 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia | Certificate Issued | 2019-09-03 | view |
JXSL1400033 | Ixekizumab(LY2439821)注射剂 | ixekizumab | Injection | Biological Products | Import Drug Application | 2014-05-30 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2016-01-12 | view |
JXSL1600042 | Ixekizumab(LY2439821)注射剂 | ixekizumab | Injection | Biological Products | Import Drug Application | 2016-08-05 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2017-07-11 | view |